Published: Aug-2022|  Format: PDF | QY Research |  Number of pages: 115 | Code: MBI-1635336

Type 2 Diabetes Medication Market by Products (Biguanides, Sulphonylureas, Thiazolidinediones, Alpha-glucosidase Inhibitors), by Applications (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 - 2028

Select a Format




 Buy Now

The Global Type 2 Diabetes Medication Market was valued at USD XXX in 2022 and it is projected to surpass around USD XX by 2030 with a registered CAGR of xxx during the forecast period 2022 to 2030.

Growth factor

Our new latest report titled, global Type 2 Diabetes Medication Market comes up with comprehensive analysis of the industry including emerging trends and current development of the market. The report offers comprehensive insights of the industry with details of market share, size, revenue, growth opportunities, regional insights and major companies. The report provides all necessary and vital information related to the global market to help the buyer, the readers, investors get a complete understanding of the market and invest accordingly to the upcoming challenges and opportunities.

List of Key Players Operating in the Market:

The report provides in-depth research about each player operating in the global Type 2 Diabetes Medication Market along with its worldwide financial position, previous and upcoming business expansion plans, new product launches. The upcoming activities of the key players related to various strategies such as acquisitions, partnerships, mergers and, joint ventures, research and development investments.

  • AstraZeneca
  • Novartis
  • Novo Nordisk
  • Johnson & Johnson
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Eli Lilly
  • Merck
  • Sanofi
  • Pfizer
  • Astellas Pharma
  • Daiichi Sankyo
  • Biocon
  • Glenmark
  • Bayer AG
  • Takeda
  • Sun pharma

Market research report presents an analysis of all the data collected through primary and secondary resources. Our well experienced team of analyst collects all the information from several leading entities press release, government publication sources such as gold standard, silver standard, white papers, articles and websites, corporate filings including financial statements, annual reports, investor presentations, etc.

Our Report offers detailed insights market valuation, volume, share, outlook, production capacity and price analysis for the forecast period 2022-2030. Furthermore, the study also includes market segmentation on the basis of product, application, end-users, supply chain, distribution channel and other segment. Additionally, the study also includes market segmentation based on upstream downstream demand analysis, feedstock, and consumption rate and market share. It employs both primary and secondary methods of data collection to obtain relevant and sustainable information of the market.

This exclusive report includes detailed information about the market related activities such as Partnerships, stake holder position, Sole Traders, which create, develop, and conduct activities for the study and analysis of markets as per the customization and specifications of the client.

Segment Analysis of the Market:

The objective of the report mainly provides an essential overview of the Type 2 Diabetes Medication Market with detailed market segmentation by product, end-users, distribution channel, technology, content, type, application and region. The global market is expected to witness rapid growth during the forecast period. The report provides growth drivers, challenges, restraints of the region. It also offers the fastest growing segment with future scope, advancement emerging trends. The study examines the global scenario of the market by conducting an economy-wide assessment along with a comprehensive study involving product costs, drivers and restrictions, demands, profit analysis, production, distribution, and year-on-year growth rates.

By Type

  • Biguanides
  • Sulphonylureas
  • Thiazolidinediones
  • Alpha-glucosidase Inhibitors
  • DPP-4 Inhibitors
  • GLP-1 Receptor Agonists
  • SGLT-2 Inhibitors
  • Insulins

By Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Key Question Answered in this In-depth Market Report 2022-2028:

  • What was the market valued in the past year?
  • What will be the projected size, share and CAGR of the market?
  • What was the market status across the globe?
  • What are the profit margins in global Type 2 Diabetes Medication Market?
  • What are the growth factors boosts the market for the forecast period?
  • Which segment is going to boom in the near future?
  • What are the upcoming trends of the market?
  • Who are the key companies or players of the market?
  • Which is the fastest growing region of the global Type 2 Diabetes Medication Market?

Regional Insights:

The government initiative increasing the development activities of the Type 2 Diabetes Medication Market. On the other hand the major reason behind the growth is the market key players are expanding their operation in this region.

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Exclusive Report Offers:

  1. To study and analyze the global Type 2 Diabetes Medication Market consumption rate by key regions, type and application, historical data from past five years, and for upcoming years.
  2. The global research study look at the market to identify key influencing factors and entry barriers.
  3. To understand the structure of market by identifying and studying its various segments.
  4. To analyze with respect to individual prospects, growth factors, emerging trends, and their contribution to the whole market.
  5. Study focuses on the analysis of key players, to describe and analyze the sales volume, company size, share, value, market competition landscape, SWOT analysis and development plans in the near future.
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Type 2 Diabetes Medication Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Biguanides
        1.2.3 Sulphonylureas
        1.2.4 Thiazolidinediones
        1.2.5 Alpha-glucosidase Inhibitors
        1.2.6 DPP-4 Inhibitors
        1.2.7 GLP-1 Receptor Agonists
        1.2.8 SGLT-2 Inhibitors
        1.2.9 Insulins
    1.3 Market by Application
        1.3.1 Global Type 2 Diabetes Medication Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Type 2 Diabetes Medication Market Perspective (2017-2028)
    2.2 Type 2 Diabetes Medication Growth Trends by Region
        2.2.1 Type 2 Diabetes Medication Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Type 2 Diabetes Medication Historic Market Size by Region (2017-2022)
        2.2.3 Type 2 Diabetes Medication Forecasted Market Size by Region (2023-2028)
    2.3 Type 2 Diabetes Medication Market Dynamics
        2.3.1 Type 2 Diabetes Medication Industry Trends
        2.3.2 Type 2 Diabetes Medication Market Drivers
        2.3.3 Type 2 Diabetes Medication Market Challenges
        2.3.4 Type 2 Diabetes Medication Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Type 2 Diabetes Medication Players by Revenue
        3.1.1 Global Top Type 2 Diabetes Medication Players by Revenue (2017-2022)
        3.1.2 Global Type 2 Diabetes Medication Revenue Market Share by Players (2017-2022)
    3.2 Global Type 2 Diabetes Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Type 2 Diabetes Medication Revenue
    3.4 Global Type 2 Diabetes Medication Market Concentration Ratio
        3.4.1 Global Type 2 Diabetes Medication Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Medication Revenue in 2021
    3.5 Type 2 Diabetes Medication Key Players Head office and Area Served
    3.6 Key Players Type 2 Diabetes Medication Product Solution and Service
    3.7 Date of Enter into Type 2 Diabetes Medication Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Type 2 Diabetes Medication Breakdown Data by Type
    4.1 Global Type 2 Diabetes Medication Historic Market Size by Type (2017-2022)
    4.2 Global Type 2 Diabetes Medication Forecasted Market Size by Type (2023-2028)
5 Type 2 Diabetes Medication Breakdown Data by Application
    5.1 Global Type 2 Diabetes Medication Historic Market Size by Application (2017-2022)
    5.2 Global Type 2 Diabetes Medication Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Type 2 Diabetes Medication Market Size (2017-2028)
    6.2 North America Type 2 Diabetes Medication Market Size by Type
        6.2.1 North America Type 2 Diabetes Medication Market Size by Type (2017-2022)
        6.2.2 North America Type 2 Diabetes Medication Market Size by Type (2023-2028)
        6.2.3 North America Type 2 Diabetes Medication Market Share by Type (2017-2028)
    6.3 North America Type 2 Diabetes Medication Market Size by Application
        6.3.1 North America Type 2 Diabetes Medication Market Size by Application (2017-2022)
        6.3.2 North America Type 2 Diabetes Medication Market Size by Application (2023-2028)
        6.3.3 North America Type 2 Diabetes Medication Market Share by Application (2017-2028)
    6.4 North America Type 2 Diabetes Medication Market Size by Country
        6.4.1 North America Type 2 Diabetes Medication Market Size by Country (2017-2022)
        6.4.2 North America Type 2 Diabetes Medication Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Type 2 Diabetes Medication Market Size (2017-2028)
    7.2 Europe Type 2 Diabetes Medication Market Size by Type
        7.2.1 Europe Type 2 Diabetes Medication Market Size by Type (2017-2022)
        7.2.2 Europe Type 2 Diabetes Medication Market Size by Type (2023-2028)
        7.2.3 Europe Type 2 Diabetes Medication Market Share by Type (2017-2028)
    7.3 Europe Type 2 Diabetes Medication Market Size by Application
        7.3.1 Europe Type 2 Diabetes Medication Market Size by Application (2017-2022)
        7.3.2 Europe Type 2 Diabetes Medication Market Size by Application (2023-2028)
        7.3.3 Europe Type 2 Diabetes Medication Market Share by Application (2017-2028)
    7.4 Europe Type 2 Diabetes Medication Market Size by Country
        7.4.1 Europe Type 2 Diabetes Medication Market Size by Country (2017-2022)
        7.4.2 Europe Type 2 Diabetes Medication Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Type 2 Diabetes Medication Market Size (2017-2028)
    8.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Type
        8.2.1 Asia-Pacific Type 2 Diabetes Medication Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Type 2 Diabetes Medication Market Share by Type (2017-2028)
    8.3 Asia-Pacific Type 2 Diabetes Medication Market Size by Application
        8.3.1 Asia-Pacific Type 2 Diabetes Medication Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Type 2 Diabetes Medication Market Share by Application (2017-2028)
    8.4 Asia-Pacific Type 2 Diabetes Medication Market Size by Region
        8.4.1 Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Type 2 Diabetes Medication Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Type 2 Diabetes Medication Market Size (2017-2028)
    9.2 Latin America Type 2 Diabetes Medication Market Size by Type
        9.2.1 Latin America Type 2 Diabetes Medication Market Size by Type (2017-2022)
        9.2.2 Latin America Type 2 Diabetes Medication Market Size by Type (2023-2028)
        9.2.3 Latin America Type 2 Diabetes Medication Market Share by Type (2017-2028)
    9.3 Latin America Type 2 Diabetes Medication Market Size by Application
        9.3.1 Latin America Type 2 Diabetes Medication Market Size by Application (2017-2022)
        9.3.2 Latin America Type 2 Diabetes Medication Market Size by Application (2023-2028)
        9.3.3 Latin America Type 2 Diabetes Medication Market Share by Application (2017-2028)
    9.4 Latin America Type 2 Diabetes Medication Market Size by Country
        9.4.1 Latin America Type 2 Diabetes Medication Market Size by Country (2017-2022)
        9.4.2 Latin America Type 2 Diabetes Medication Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Type 2 Diabetes Medication Market Size (2017-2028)
    10.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Type
        10.2.1 Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Type 2 Diabetes Medication Market Share by Type (2017-2028)
    10.3 Middle East & Africa Type 2 Diabetes Medication Market Size by Application
        10.3.1 Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Type 2 Diabetes Medication Market Share by Application (2017-2028)
    10.4 Middle East & Africa Type 2 Diabetes Medication Market Size by Country
        10.4.1 Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Details
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Type 2 Diabetes Medication Introduction
        11.1.4 AstraZeneca Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.1.5 AstraZeneca Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Type 2 Diabetes Medication Introduction
        11.2.4 Novartis Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.2.5 Novartis Recent Developments
    11.3 Novo Nordisk
        11.3.1 Novo Nordisk Company Details
        11.3.2 Novo Nordisk Business Overview
        11.3.3 Novo Nordisk Type 2 Diabetes Medication Introduction
        11.3.4 Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.3.5 Novo Nordisk Recent Developments
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Type 2 Diabetes Medication Introduction
        11.4.4 Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Developments
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Details
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Type 2 Diabetes Medication Introduction
        11.5.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.5.5 Boehringer Ingelheim Recent Developments
    11.6 Bristol-Myers Squibb
        11.6.1 Bristol-Myers Squibb Company Details
        11.6.2 Bristol-Myers Squibb Business Overview
        11.6.3 Bristol-Myers Squibb Type 2 Diabetes Medication Introduction
        11.6.4 Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.6.5 Bristol-Myers Squibb Recent Developments
    11.7 Eli Lilly
        11.7.1 Eli Lilly Company Details
        11.7.2 Eli Lilly Business Overview
        11.7.3 Eli Lilly Type 2 Diabetes Medication Introduction
        11.7.4 Eli Lilly Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.7.5 Eli Lilly Recent Developments
    11.8 Merck
        11.8.1 Merck Company Details
        11.8.2 Merck Business Overview
        11.8.3 Merck Type 2 Diabetes Medication Introduction
        11.8.4 Merck Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.8.5 Merck Recent Developments
    11.9 Sanofi
        11.9.1 Sanofi Company Details
        11.9.2 Sanofi Business Overview
        11.9.3 Sanofi Type 2 Diabetes Medication Introduction
        11.9.4 Sanofi Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.9.5 Sanofi Recent Developments
    11.10 Pfizer
        11.10.1 Pfizer Company Details
        11.10.2 Pfizer Business Overview
        11.10.3 Pfizer Type 2 Diabetes Medication Introduction
        11.10.4 Pfizer Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.10.5 Pfizer Recent Developments
    11.11 Astellas Pharma
        11.11.1 Astellas Pharma Company Details
        11.11.2 Astellas Pharma Business Overview
        11.11.3 Astellas Pharma Type 2 Diabetes Medication Introduction
        11.11.4 Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.11.5 Astellas Pharma Recent Developments
    11.12 Daiichi Sankyo
        11.12.1 Daiichi Sankyo Company Details
        11.12.2 Daiichi Sankyo Business Overview
        11.12.3 Daiichi Sankyo Type 2 Diabetes Medication Introduction
        11.12.4 Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.12.5 Daiichi Sankyo Recent Developments
    11.13 Biocon
        11.13.1 Biocon Company Details
        11.13.2 Biocon Business Overview
        11.13.3 Biocon Type 2 Diabetes Medication Introduction
        11.13.4 Biocon Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.13.5 Biocon Recent Developments
    11.14 Glenmark
        11.14.1 Glenmark Company Details
        11.14.2 Glenmark Business Overview
        11.14.3 Glenmark Type 2 Diabetes Medication Introduction
        11.14.4 Glenmark Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.14.5 Glenmark Recent Developments
    11.15 Bayer AG
        11.15.1 Bayer AG Company Details
        11.15.2 Bayer AG Business Overview
        11.15.3 Bayer AG Type 2 Diabetes Medication Introduction
        11.15.4 Bayer AG Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.15.5 Bayer AG Recent Developments
    11.16 Takeda
        11.16.1 Takeda Company Details
        11.16.2 Takeda Business Overview
        11.16.3 Takeda Type 2 Diabetes Medication Introduction
        11.16.4 Takeda Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.16.5 Takeda Recent Developments
    11.17 Sun pharma
        11.17.1 Sun pharma Company Details
        11.17.2 Sun pharma Business Overview
        11.17.3 Sun pharma Type 2 Diabetes Medication Introduction
        11.17.4 Sun pharma Revenue in Type 2 Diabetes Medication Business (2017-2022)
        11.17.5 Sun pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables Table 1. Global Type 2 Diabetes Medication Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Biguanides Table 3. Key Players of Sulphonylureas Table 4. Key Players of Thiazolidinediones Table 5. Key Players of Alpha-glucosidase Inhibitors Table 6. Key Players of DPP-4 Inhibitors Table 7. Key Players of GLP-1 Receptor Agonists Table 8. Key Players of SGLT-2 Inhibitors Table 9. Key Players of Insulins Table 10. Global Type 2 Diabetes Medication Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 11. Global Type 2 Diabetes Medication Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 12. Global Type 2 Diabetes Medication Market Size by Region (2017-2022) & (US$ Million) Table 13. Global Type 2 Diabetes Medication Market Share by Region (2017-2022) Table 14. Global Type 2 Diabetes Medication Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 15. Global Type 2 Diabetes Medication Market Share by Region (2023-2028) Table 16. Type 2 Diabetes Medication Market Trends Table 17. Type 2 Diabetes Medication Market Drivers Table 18. Type 2 Diabetes Medication Market Challenges Table 19. Type 2 Diabetes Medication Market Restraints Table 20. Global Type 2 Diabetes Medication Revenue by Players (2017-2022) & (US$ Million) Table 21. Global Type 2 Diabetes Medication Revenue Share by Players (2017-2022) Table 22. Global Top Type 2 Diabetes Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medication as of 2021) Table 23. Ranking of Global Top Type 2 Diabetes Medication Companies by Revenue (US$ Million) in 2021 Table 24. Global 5 Largest Players Market Share by Type 2 Diabetes Medication Revenue (CR5 and HHI) & (2017-2022) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Type 2 Diabetes Medication Product Solution and Service Table 27. Date of Enter into Type 2 Diabetes Medication Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million) Table 30. Global Type 2 Diabetes Medication Revenue Market Share by Type (2017-2022) Table 31. Global Type 2 Diabetes Medication Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 32. Global Type 2 Diabetes Medication Revenue Market Share by Type (2023-2028) Table 33. Global Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million) Table 34. Global Type 2 Diabetes Medication Revenue Share by Application (2017-2022) Table 35. Global Type 2 Diabetes Medication Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 36. Global Type 2 Diabetes Medication Revenue Share by Application (2023-2028) Table 37. North America Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million) Table 38. North America Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million) Table 39. North America Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million) Table 40. North America Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million) Table 41. North America Type 2 Diabetes Medication Market Size by Country (2017-2022) & (US$ Million) Table 42. North America Type 2 Diabetes Medication Market Size by Country (2023-2028) & (US$ Million) Table 43. Europe Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million) Table 44. Europe Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million) Table 45. Europe Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million) Table 46. Europe Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million) Table 47. Europe Type 2 Diabetes Medication Market Size by Country (2017-2022) & (US$ Million) Table 48. Europe Type 2 Diabetes Medication Market Size by Country (2023-2028) & (US$ Million) Table 49. Asia Pacific Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million) Table 50. Asia Pacific Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million) Table 51. Asia Pacific Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million) Table 52. Asia Pacific Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million) Table 53. Asia Pacific Type 2 Diabetes Medication Market Size by Region (2017-2022) & (US$ Million) Table 54. Asia Pacific Type 2 Diabetes Medication Market Size by Region (2023-2028) & (US$ Million) Table 55. Latin America Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million) Table 56. Latin America Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million) Table 57. Latin America Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million) Table 58. Latin America Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million) Table 59. Latin America Type 2 Diabetes Medication Market Size by Country (2017-2022) & (US$ Million) Table 60. Latin America Type 2 Diabetes Medication Market Size by Country (2023-2028) & (US$ Million) Table 61. Middle East and Africa Type 2 Diabetes Medication Market Size by Type (2017-2022) & (US$ Million) Table 62. Middle East and Africa Type 2 Diabetes Medication Market Size by Type (2023-2028) & (US$ Million) Table 63. Middle East and Africa Type 2 Diabetes Medication Market Size by Application (2017-2022) & (US$ Million) Table 64. Middle East and Africa Type 2 Diabetes Medication Market Size by Application (2023-2028) & (US$ Million) Table 65. Middle East and Africa Type 2 Diabetes Medication Market Size by Country (2017-2022) & (US$ Million) Table 66. Middle East and Africa Type 2 Diabetes Medication Market Size by Country (2023-2028) & (US$ Million) Table 67. AstraZeneca Company Details Table 68. AstraZeneca Business Overview Table 69. AstraZeneca Type 2 Diabetes Medication Product Table 70. AstraZeneca Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 71. AstraZeneca Recent Developments Table 72. Novartis Company Details Table 73. Novartis Business Overview Table 74. Novartis Type 2 Diabetes Medication Product Table 75. Novartis Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 76. Novartis Recent Developments Table 77. Novo Nordisk Company Details Table 78. Novo Nordisk Business Overview Table 79. Novo Nordisk Type 2 Diabetes Medication Product Table 80. Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 81. Novo Nordisk Recent Developments Table 82. Johnson & Johnson Company Details Table 83. Johnson & Johnson Business Overview Table 84. Johnson & Johnson Type 2 Diabetes Medication Product Table 85. Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 86. Johnson & Johnson Recent Developments Table 87. Boehringer Ingelheim Company Details Table 88. Boehringer Ingelheim Business Overview Table 89. Boehringer Ingelheim Type 2 Diabetes Medication Product Table 90. Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 91. Boehringer Ingelheim Recent Developments Table 92. Bristol-Myers Squibb Company Details Table 93. Bristol-Myers Squibb Business Overview Table 94. Bristol-Myers Squibb Type 2 Diabetes Medication Product Table 95. Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 96. Bristol-Myers Squibb Recent Developments Table 97. Eli Lilly Company Details Table 98. Eli Lilly Business Overview Table 99. Eli Lilly Type 2 Diabetes Medication Product Table 100. Eli Lilly Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 101. Eli Lilly Recent Developments Table 102. Merck Company Details Table 103. Merck Business Overview Table 104. Merck Type 2 Diabetes Medication Product Table 105. Merck Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 106. Merck Recent Developments Table 107. Sanofi Company Details Table 108. Sanofi Business Overview Table 109. Sanofi Type 2 Diabetes Medication Product Table 110. Sanofi Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 111. Sanofi Recent Developments Table 112. Pfizer Company Details Table 113. Pfizer Business Overview Table 114. Pfizer Type 2 Diabetes Medication Product Table 115. Pfizer Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 116. Pfizer Recent Developments Table 117. Astellas Pharma Company Details Table 118. Astellas Pharma Business Overview Table 119. Astellas Pharma Type 2 Diabetes Medication Product Table 120. Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 121. Astellas Pharma Recent Developments Table 122. Daiichi Sankyo Company Details Table 123. Daiichi Sankyo Business Overview Table 124. Daiichi Sankyo Type 2 Diabetes Medication Product Table 125. Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 126. Daiichi Sankyo Recent Developments Table 127. Biocon Company Details Table 128. Biocon Business Overview Table 129. Biocon Type 2 Diabetes Medication Product Table 130. Biocon Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 131. Biocon Recent Developments Table 132. Glenmark Company Details Table 133. Glenmark Business Overview Table 134. Glenmark Type 2 Diabetes Medication Product Table 135. Glenmark Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 136. Glenmark Recent Developments Table 137. Bayer AG Company Details Table 138. Bayer AG Business Overview Table 139. Bayer AG Type 2 Diabetes Medication Product Table 140. Bayer AG Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 141. Bayer AG Recent Developments Table 142. Takeda Company Details Table 143. Takeda Business Overview Table 144. Takeda Type 2 Diabetes Medication Product Table 145. Takeda Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 146. Takeda Recent Developments Table 147. Sun pharma Company Details Table 148. Sun pharma Business Overview Table 149. Sun pharma Type 2 Diabetes Medication Product Table 150. Sun pharma Revenue in Type 2 Diabetes Medication Business (2017-2022) & (US$ Million) Table 151. Sun pharma Recent Developments Table 152. Research Programs/Design for This Report Table 153. Key Data Information from Secondary Sources Table 154. Key Data Information from Primary Sources List of Figures Figure 1. Global Type 2 Diabetes Medication Market Share by Type: 2021 VS 2028 Figure 2. Biguanides Features Figure 3. Sulphonylureas Features Figure 4. Thiazolidinediones Features Figure 5. Alpha-glucosidase Inhibitors Features Figure 6. DPP-4 Inhibitors Features Figure 7. GLP-1 Receptor Agonists Features Figure 8. SGLT-2 Inhibitors Features Figure 9. Insulins Features Figure 10. Global Type 2 Diabetes Medication Market Share by Application: 2021 VS 2028 Figure 11. Hospital Pharmacies Case Studies Figure 12. Retail Pharmacies Case Studies Figure 13. Online Pharmacies Case Studies Figure 14. Type 2 Diabetes Medication Report Years Considered Figure 15. Global Type 2 Diabetes Medication Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 16. Global Type 2 Diabetes Medication Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 17. Global Type 2 Diabetes Medication Market Share by Region: 2021 VS 2028 Figure 18. Global Type 2 Diabetes Medication Market Share by Players in 2021 Figure 19. Global Top Type 2 Diabetes Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Medication as of 2021) Figure 20. The Top 10 and 5 Players Market Share by Type 2 Diabetes Medication Revenue in 2021 Figure 21. North America Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million) Figure 22. North America Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028) Figure 23. North America Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028) Figure 24. North America Type 2 Diabetes Medication Market Size Share by Country (2017-2028) Figure 25. United States Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Canada Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Europe Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million) Figure 28. Europe Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028) Figure 29. Europe Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028) Figure 30. Europe Type 2 Diabetes Medication Market Size Share by Country (2017-2028) Figure 31. Germany Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. France Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. U.K. Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Italy Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Russia Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Nordic Countries Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Asia-Pacific Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million) Figure 38. Asia Pacific Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028) Figure 39. Asia Pacific Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028) Figure 40. Asia Pacific Type 2 Diabetes Medication Market Size Share by Region (2017-2028) Figure 41. China Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Japan Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. South Korea Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Southeast Asia Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. India Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Australia Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 47. Latin America Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million) Figure 48. Latin America Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028) Figure 49. Latin America Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028) Figure 50. Latin America Type 2 Diabetes Medication Market Size Share by Country (2017-2028) Figure 51. Mexico Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Brazil Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Middle East & Africa Type 2 Diabetes Medication Market Size YoY (2017-2028) & (US$ Million) Figure 54. Middle East and Africa Type 2 Diabetes Medication Market Size Market Share by Type (2017-2028) Figure 55. Middle East and Africa Type 2 Diabetes Medication Market Size Market Share by Application (2017-2028) Figure 56. Middle East and Africa Type 2 Diabetes Medication Market Size Share by Country (2017-2028) Figure 57. Turkey Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. Saudi Arabia Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 59. UAE Type 2 Diabetes Medication Market Size YoY Growth (2017-2028) & (US$ Million) Figure 60. AstraZeneca Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 61. Novartis Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 62. Novo Nordisk Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 63. Johnson & Johnson Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 64. Boehringer Ingelheim Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 66. Eli Lilly Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 67. Merck Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 68. Sanofi Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 69. Pfizer Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 70. Astellas Pharma Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 71. Daiichi Sankyo Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 72. Biocon Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 73. Glenmark Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 74. Bayer AG Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 75. Takeda Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 76. Sun pharma Revenue Growth Rate in Type 2 Diabetes Medication Business (2017-2022) Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed



Inquiry before buying

Request Sample

Request for Discount

Latest News

Global UAV Propulsion System Market to Grow at a (CAGR) of 11.8% during the Forecast Period 2022-2030

26-Sep-2022 | Semiconductor

As specified in the market business insights exclusive report, the global UAV Propulsion System Market is projected to reach USD 34,258.31 million by 2030. Growth Drivers: Market dynamics are the forces that influence the prices and b ...

Global Autonomous Vehicle Simulation Solution Market to Grow at a (CAGR) of 12.8% during the Forecast Period 2022-2030

24-Sep-2022 | Automobile

As specified in our exclusive report, the global Autonomous Vehicle Simulation Solution Market is projected to reach USD 2,515 Million by 2030. Growth Drivers: Increasing adoption of connected ve ...

Global Active Space Debris Removal Market to Grow at a (CAGR) of 23.9% during the Forecast Period 2022-2030

23-Sep-2022 | Aerospace & Defense

As specified in our exclusive report, the Global  Active Space Debris Removal Market size is projected to reach USD 452.65 million by 2030. According to the European Space Agency (ESA), there have been more than 5,000 launches into space ...

Global Small Arms Market to Grow at a (CAGR) of 4.8% during the Forecast Period 2022-2030

22-Sep-2022 | Aerospace & Defense

As specified in our exclusive report, the Global Small Arms Market is projected to reach USD 12.88 billion by 2030. The defense sector is upgrading weapons and ammunition and adopting more modern weapon systems, and deployments at military bases, i ...

Global RFID in Healthcare Market to Grow at a (CAGR) of 21.5% during the Forecast Period 2022-2030

21-Sep-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global RFID in Healthcare Market is projected to reach USD 12.06 billion by 2030. How RFID is Use in Healthcare Market? RFID applications in healthcare have been positi ...

More News...